| Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity (NCT00513487) | Novartis | 2007-07-01 |
| The Effect of Omalizumab on Responses to Cat Allergen Challenge (NCT00604786) | Johns Hopkins University | 2007-07-01 |
| Intranasal Steroids and Oxymetazoline in Allergic Rhinitis (NCT00584987) | University of Chicago | 2007-06-01 |
| The Anti-allergic Effects of Specific Probiotics (NCT00480129) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2007-05-01 |
| Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) (NCT00458835) | Covis Pharma S.à.r.l. | 2007-04-01 |
| Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements (NCT00466596) | University of North Carolina, Chapel Hill | 2007-03-01 |
| Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (NCT01728285) | ALK-Abelló A/S | 2007-03-01 |
| A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis (NCT01448902) | Oxagen Ltd | 2007-03-01 |
| Dietary Intake in Adults From the GA2LEN Folow-up Survey (NCT03251157) | Johns Hopkins Bloomberg School of Public Health | 2007-01-01 |
| Allergen Immunotherapy in Allergic Patients (NCT02040974) | Istanbul University | 2007-01-01 |
| Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis (NCT00903227) | University of Dundee | 2006-12-01 |
| Fluticasone and Salmeterol in Allergic Rhinitis (NCT01388595) | University of Dundee | 2006-11-01 |
| Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis (NCT01382654) | Merck Sharp & Dohme LLC | 2006-09-01 |
| Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) (NCT00405964) | Organon and Co | 2006-09-01 |
| Effect of a Probiotic on Grass Pollen Allergic Rhinitis Subjects (NCT01150253) | Société des Produits Nestlé (SPN) | 2006-08-01 |
| Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism (NCT00362999) | Children's Mercy Hospital Kansas City | 2006-08-01 |
| Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis (NCT00355771) | Institut für Atemwegsforschung GmbH | 2006-06-01 |
| Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug (NCT00318747) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis (NCT00400998) | Research Consult GmbH | 2006-03-01 |
| Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development (NCT00713089) | National University Hospital, Singapore | 2006-03-01 |
| Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma (NCT00286416) | Scripps Clinic | 2006-01-01 |
| To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis (NCT00679250) | Brian J Lipworth | 2005-11-01 |
| Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) (NCT00348361) | GlaxoSmithKline | 2005-04-01 |
| Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) (NCT00163488) | AstraZeneca | 2005-01-01 |
| Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies (NCT01529437) | Stanford University | 2005-01-01 |
| Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) (NCT00442559) | Organon and Co | 2005-01-01 |
| Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208) (NCT00783458) | Organon and Co | 2004-12-01 |
| Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207) (NCT00817050) | Organon and Co | 2004-12-01 |
| Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease (NCT00569361) | Centre Hospitalier Universitaire de Nice | 2004-11-01 |
| Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED) (NCT00794378) | Organon and Co | 2004-11-01 |
| Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826) (NCT00794794) | Organon and Co | 2004-11-01 |
| Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis (NCT00152412) | UCB Pharma | 2004-06-01 |
| Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses (NCT00318695) | National University Hospital, Singapore | 2004-05-01 |
| Assess the Efficacy and Safety of Rhinocort Aqua (NCT00641693) | AstraZeneca | 2004-04-01 |
| Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) (NCT00367016) | University of California, Davis | 2004-02-01 |
| Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431) (NCT00783237) | Organon and Co | 2003-12-01 |
| Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) (NCT00163501) | AstraZeneca | 2003-12-01 |
| The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609) (NCT00789152) | Organon and Co | 2003-12-01 |
| CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis (NCT00631254) | Laval University | 2003-10-01 |
| Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen (NCT00638118) | Sanofi | 2003-02-01 |
| A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329) (NCT00157937) | Organon and Co | 2003-02-01 |
| Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine (NCT00636870) | Sanofi | 2003-02-01 |
| Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine (NCT00637585) | Sanofi | 2002-12-01 |
| Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) (NCT02932774) | Johnson & Johnson Consumer and Personal Products Worldwide | 2001-03-01 |
| Controlled Exposure to Diesel Exhaust in Subjects With Allergic Rhinitis (NCT01617330) | University Hospital, Umeå | 2001-03-01 |
| A Trial of Point of Care Information in Ambulatory Pediatrics (NCT00368823) | University of Washington | 1999-11-01 |
| Pollutant Altered Allergic Responses (NCT00011440) | National Institute of Environmental Health Sciences (NIEHS) | 1998-12-01 |
| Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge (NCT01657097) | University of Aarhus | 1997-02-01 |
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders (NCT00557895) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-26 |
| An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo (NCT01076439) | ORA, Inc. | |
| The Effects of OC000459 on Nasal Mediators (NCT00290381) | Trevor Hansel | |
| Phase 2 Study in Adults Sensitized to Short Ragweed (NCT00670384) | Antigen Laboratories, Inc. | |
| Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis (NCT00189449) | West Penn Allegheny Health System | |